ROYCE & ASSOCIATES LP - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$1,466,000
+11.1%
20,000
-35.7%
0.01%0.0%
Q4 2018$1,319,000
-10.0%
31,1000.0%0.01%
+20.0%
Q3 2018$1,465,000
-41.8%
31,100
-39.1%
0.01%
-41.2%
Q2 2018$2,519,000
+34.3%
51,100
-16.4%
0.02%
+30.8%
Q1 2018$1,876,000
-15.1%
61,100
-49.5%
0.01%
-13.3%
Q4 2017$2,210,000
-24.8%
121,100
-51.8%
0.02%
-21.1%
Q3 2017$2,938,000
+220.4%
251,1000.0%0.02%
+216.7%
Q2 2017$917,000
+32.5%
251,100
+88.7%
0.01%
+20.0%
Q1 2017$692,000133,0370.01%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders